Key facts
- This page summarizes Alessandrea C. Quane's Form 4 filing for Oscar Health, Inc. (OSCR).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Dec 2024, 16:41.
Alessandrea C. Quane - 05 Dec 2024 Form 4 Insider Report for Oscar Health, Inc. (OSCR)
- Reporting relationship
- EVP, Chief Insurance Officer
- Issuer ticker
- OSCR
- Reported as of
- 05 Dec 2024
- Net transaction value
- -$271,293
- SEC form
- 4
- Accepted by SEC
- 09 Dec 2024, 16:41:04 UTC
- Prior SEC filing
- 03 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Melissa Curtin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alessandrea C. Quane filed Form 4 for Oscar Health, Inc. (OSCR) on 09 Dec 2024.
Change
- Previous filing in this sequence was filed on 03 Dec 2024.
- Current net transaction value: -$271,293.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OSCR
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +31,250
- Change %
- +7.5%
- Price
- Shares after
- 447,009
- Date
- 05 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
OSCR
transaction
Class A Common Stock
Sale
- Transaction value
- $165,433
- Shares
- -10,385
- Change %
- -2.3%
- Price
- $15.93
- Shares after
- 436,624
- Date
- 06 Dec 2024
- Ownership
- Direct
- Footnotes
- F2, F3
OSCR
transaction
Class A Common Stock
Sale
- Transaction value
- $105,860
- Shares
- -6,408
- Change %
- -1.5%
- Price
- $16.52
- Shares after
- 430,216
- Date
- 06 Dec 2024
- Ownership
- Direct
- Footnotes
- F2, F4
OSCR
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 76,857
- Date
- 05 Dec 2024
- Ownership
- Alessandrea C Quane 2024 GRAT
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OSCR
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -31,250
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 05 Dec 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 31,250
- Exercise price
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
Footnote F2
The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Footnote F5
The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.